Clinical Trial Update: Study to Evaluate MEDI-534 in Healthy Adults

View source ↗

Summary

This completed study evaluated MEDI-534 in healthy adults to assess safety for Respiratory Syncytial Virus and Parainfluenza infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parainfluenza Infections
• Respiratory Syncytial Virus Infections

Drugs mentioned

• MEDI-534

Snippet

Sponsor: MedImmune LLC | Conditions: Respiratory Syncytial Virus Infections, Parainfluenza Infections | Status: COMPLETED